Passer au contenu principal

5-methyltetrahydrofolate-homocysteine methyltransferase

La MTR gene provides instructions for making an enzyme called methionine synthase. This enzyme plays a role in processing amino acids, the building blocks of proteins. Specifically, methionine synthase carries out a chemical reaction that converts the amino acid homocysteine to another amino acid called methionine. The body uses methionine to make proteins and other important compounds. To function properly, methionine synthase requires methylcobalamin (a form of vitamin B12) and another enzyme called methionine synthase reductase, which is produced from the MTRR gene.

Normal function

La MTR gene provides instructions for making an enzyme called methionine synthase. This enzyme plays a role in processing amino acids, the building blocks of proteins. Specifically, methionine synthase carries out a chemical reaction that converts the amino acid homocysteine to another amino acid called methionine. The body uses methionine to make proteins and other important compounds. To function properly, methionine synthase requires methylcobalamin (a form of vitamin B12) and another enzyme called methionine synthase reductase, which is produced from the MTRR gene.

Conditions referring to this gene or chromosome

Other names

5-methyltetrahydrofolate-homocysteine methyltransferase 1

5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase

cblG

cobalamin-dependent methionine synthase

Homocysteine-methyl tetrahydrofolate methyltransferase

METH_HUMAN

Methionine Synthase

Tetrahydropteroylglutamate Methyltransferase

Related patient information and medicines

la maladie de Kawasaki

Patient information leaflet

la maladie de Kawasaki

la maladie de Kawasaki is a rare condition that affects small to medium-sized blood vessels in the body. Kawasaki disease causes the the walls of the blood vessels to become inflamed and swollen (vasculitis). Kawasaki disease mainly affects children less than 5 years old. The exact cause of Kawasaki disease remains unknown. Kawasaki disease causes a.

Voyager vers des lieux éloignés

Patient information leaflet

Voyager vers des lieux éloignés

It is so that if you seek medical help from doctors and nurses in the country where you are travelling, they can advise you wha... Self-treatment is a last resort as it is very difficult for anyone to make treatment decisions about themselves. Reference book Pocket First Aid and Wilderness Medicine: Drs Jim Duff and Peter Gormly (2010). This is an.

maladie de Parkinson

Patient information leaflet

maladie de Parkinson

maladie de Parkinson is a progressive neurological degeneration of certain cells (called dopaminergic cells) within a specific part of the brain (substantia nigra). The deficiency of dopamine leads to a movement disorder with Parkinson's disease symptoms. The National Institute for Health and Care Excellence (NICE) has just approved a few devices.

Macrocytose et anémie macrocytaire

Patient information leaflet

Macrocytose et anémie macrocytaire

Macrocytosis refers to red blood cells which are larger than normal. It does not cause any symptoms in itself. Macrocytosis symptoms You may also find relevant information in our other separate leaflet called What is blood. Macrocytosis can exist without anaemia. Macrocytosis itself does not cause any symptoms but can be a sign of low levels of.

Pancréatite aiguë

Patient information leaflet

Pancréatite aiguë

It is occasionally possible to have acute pancreatitis without any pain; this is more common in people with diabetes or kidney problems. Being sick (vomiting). A high temperature (fever) and generally feeling very unwell are common. Swollen abdomen. If the pancreatitis becomes severe and other organs become involved (for example, the heart, lungs.

Maladie polykystique des reins

Patient information leaflet

Maladie polykystique des reins

Polycystic kidney disease (PKD) causes many fluid-filled sacs (cysts) to develop in the kidneys. The most common type of PKD is an inherited condition called autosomal dominant polycystic kidney disease (ADPKD). With ADPKD, problems commonly do not develop until the age of 30-50, with some people never developing any problems. About half of ADPKD.

Lectures complémentaires et références

Historique de l'article

Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.
  • 8 mai 2023 | Dernière version
  • 1 Jul 2011 | Publié à l'origine

Participez à la conversation

Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.

Avertissement : The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.
vérificateur d'éligibilité à la grippe

Demandez, partagez, connectez-vous.

Parcourez les discussions, posez des questions et partagez vos expériences sur des centaines de sujets de santé.

Inscrivez-vous à la newsletter Patient

Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.

Veuillez entrer une adresse e-mail valide

En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.